TVTY

Tivity Health, Inc. [TVTY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TVTY Stock Summary

In the News

09:28 29 Mar 2024 TVTY

Tivity Health stock jumps after Stone Point buyout deal valued at $2 billion

Shares of Tivity Health Inc. TVTY, -1.10% rallied 1.6% in premarket trading Tuesday, after the fitness, nutrition and social connection company announced an agreement to be acquired by private equity firm Stone Point Capital in a deal valued at $2.0 billion. Under terms of the deal, Stone Point will pay $32.50 for each Tivity shares outstanding, which is 0.8% above Monday's closing price of $32.25, but represents a 20% premium to the 90-day volume-weighted average price (VWAP) ending April 4.

09:02 29 Mar 2024 TVTY

Tivity Health (TVTY) Moves 5.2% Higher: Will This Strength Last?

Tivity Health (TVTY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

11:17 29 Mar 2024 TVTY

Is Tivity Health (TVTY) a Suitable Stock for Value Investors?

Let's see if Tivity Health, Inc. (TVTY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

11:22 29 Mar 2024 TVTY

Tivity Health, Inc. (TVTY) CEO Richard Ashworth on Q4 2021 Results - Earnings Call Transcript

Tivity Health, Inc. (TVTY) CEO Richard Ashworth on Q4 2021 Results - Earnings Call Transcript

08:00 29 Mar 2024 TVTY

Tivity Health (TVTY) Lags Q4 Earnings Estimates

Tivity Health (TVTY) delivered earnings and revenue surprises of -21.05% and 0.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

12:19 29 Mar 2024 TVTY

Tivity Health (TVTY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Tivity Health (TVTY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

01:05 29 Mar 2024 TVTY

TVTY or DOCS: Which Is the Better Value Stock Right Now?

TVTY vs. DOCS: Which Stock Is the Better Value Option?

04:05 29 Mar 2024 TVTY

Tivity Health to Present at the 40th Annual J.P. Morgan Healthcare Conference

NASHVILLE, Tenn., Dec. 21, 2021 /PRNewswire/ -- Tivity Health, Inc. (Nasdaq: TVTY) will attend the 40th Annual J.P.

05:00 29 Mar 2024 TVTY

Tivity Health to Participate in Upcoming Investor Conference

NASHVILLE, Tenn., Nov. 4, 2021 /PRNewswire/ -- Tivity Health, Inc. (Nasdaq: TVTY) today announced that it will participate in the following virtual investor conference: The Credit Suisse Annual Healthcare Conference including a presentation with Richard Ashworth, President & Chief Executive Officer, Adam Holland, Chief Financial Officer and Tommy Lewis, Chief Operating Officer on Wednesday, November 10, 2021.

10:34 29 Mar 2024 TVTY

Tivity Health, Inc. (TVTY) CEO Richard Ashworth on Q3 2021 Results - Earnings Call Transcript

Tivity Health, Inc. (TVTY) CEO Richard Ashworth on Q3 2021 Results - Earnings Call Transcript

TVTY Financial details

Company Rating
Strong Buy
Market Cap
0
Income
88.08M
Revenue
500.68M
Book val./share
2.53
Cash/share
2.36
Dividend
-
Dividend %
-
Employees
380
Optionable
No
Shortable
Yes
Earnings
03 Aug 2022
P/E
14.75
Forward P/E
-
PEG
2.75
P/S
-
P/B
13.32
P/C
-
P/FCF
-
Quick Ratio
2.01
Current Ratio
2.24
Debt / Equity
3.04
LT Debt / Equity
2.99
-
-
EPS (TTM)
1.78
EPS next Y
-
EPS next Q
-
EPS this Y
87.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.92%
Revenue last 5Y
-2.88%
Revenue Q/Q
0.56%
EPS Q/Q
-102.54%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
88.9%
Inst Trans
0.97%
ROA
18%
ROE
175%
ROC
0.32%
Gross Margin
42%
Oper. Margin
34%
Profit Margin
22%
Payout
-
Shs Outstand
49.93M
Shs Float
34.31M
-
-
-
-
Target Price
-
52W Range
32.48-32.5
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
1.01M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
2.14111
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

TVTY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
14.1514.0824.328.899.78
Net income per share
1.562.27-6.171.162.18
Operating cash flow per share
2.672.521.773.441.77
Free cash flow per share
2.522.311.243.131.47
Cash per share
0.720.040.052.042.23
Book value per share
6.918.574.880.072.42
Tangible book value per share
-2.330.12-24.03-7.32-4.97
Share holders equity per share
6.918.574.880.072.42
Interest debt per share
4.110.9124.4810.538.67
Market cap
1.44B1.07B946.23M964.16M1.3B
Enterprise value
1.56B1.1B2.01B1.34B1.63B
P/E ratio
23.4910.92-3.316.9512.12
Price to sales ratio
2.581.760.842.22.7
POCF ratio
13.669.8311.55.6914.94
PFCF ratio
14.4810.7216.436.2617.98
P/B Ratio
5.292.94.17263.7210.94
PTB ratio
5.292.94.17263.7210.94
EV to sales
2.791.811.773.063.39
Enterprise value over EBITDA
12.337.88-10.08-11.479.21
EV to operating cash flow
14.7810.0924.377.918.75
EV to free cash flow
15.6611.0134.828.722.57
Earnings yield
0.040.09-0.30.060.08
Free cash flow yield
0.070.090.060.160.06
Debt to equity
0.540.084.68129.863.3
Debt to assets
0.230.060.650.820.65
Net debt to EBITDA
0.930.21-5.32-3.211.87
Current ratio
0.620.961.111.882.24
Interest coverage
7.8715.41-3.26-3.744.78
Income quality
1.651.1-0.29-0.760.83
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.060.10.10.09
Research and developement to revenue
00000
Intangibles to total assets
0.570.750.830.630.61
Capex to operating cash flow
-0.06-0.08-0.3-0.09-0.17
Capex to revenue
-0.01-0.01-0.02-0.04-0.03
Capex to depreciation
-1.76-1.94-0.49-0.34-1.31
Stock based compensation to revenue
0.010.010.020.030.02
Graham number
15.5520.9326.021.3910.89
ROIC
0.170.26-0.16-0.250.26
Return on tangible assets
0.220.83-1.020.260.46
Graham Net
-7.48-1.4-28.06-9.09-6.51
Working capital
-135.34M-2.97M15.38M72.42M108.48M
Tangible asset value
-91.78M5.27M-1.12B-360.07M-244.82M
Net current asset value
-140.92M-34.97M-1.24B-421.07M-283.73M
Invested capital
0.540.084.68129.863.3
Average receivables
53M61.51M82.73M67.29M51.4M
Average payables
26.42M27.95M37.79M33.11M22.53M
Average inventory
0018.2M18.2M0
Days sales outstanding
36.1440.8531.4930.8349.92
Days payables outstanding
24.7324.5525.0228.7833.22
Days of inventory on hand
0019.600
Receivables turnover
10.18.9311.5911.847.31
Payables turnover
14.7614.8714.5912.6810.99
Inventory turnover
0018.6200
ROE
0.230.27-1.2615.550.9
Capex per share
-0.15-0.21-0.53-0.32-0.3

Quarterly Fundamentals Overview

Last date of statement is 2022-03-31 for Q1

Metric History 2021-03-312021-06-302021-09-302021-12-31 2022-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.22.432.542.552.52
Net income per share
0.410.182.09-0.50.01
Operating cash flow per share
0.460.280.580.440.73
Free cash flow per share
0.430.230.530.280.68
Cash per share
1.070.492.872.212.36
Book value per share
0.530.72.832.392.53
Tangible book value per share
-6.86-6.65-4.49-4.92-4.66
Share holders equity per share
0.530.72.832.392.53
Interest debt per share
8.818.38.168.027.84
Market cap
1.1B1.3B1.15B1.32B1.63B
Enterprise value
1.47B1.68B1.49B1.65B1.92B
P/E ratio
13.7737.12.76-13.15631.37
Price to sales ratio
10.1610.849.0810.3812.75
POCF ratio
48.5794.2339.8360.1243.94
PFCF ratio
52.17114.8443.8195.3747.42
P/B Ratio
41.8537.428.1511.0712.71
PTB ratio
41.8537.428.1511.0712.71
EV to sales
13.5913.9811.831315.09
Enterprise value over EBITDA
36.5581.1512.26-307.6101.97
EV to operating cash flow
64.95121.5251.8875.2751.97
EV to free cash flow
69.76148.0957.06119.4156.09
Earnings yield
0.020.010.09-0.020
Free cash flow yield
0.020.010.020.010.02
Debt to equity
16.111.532.833.33.04
Debt to assets
0.780.770.630.650.65
Net debt to EBITDA
9.2118.222.85-61.9315.76
Current ratio
1.371.272.472.242.47
Interest coverage
3.491.9116.19-1.172.24
Income quality
1.181.650.28-0.8663.71
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.090.080.080.090.08
Research and developement to revenue
00000
Intangibles to total assets
0.670.690.580.610.61
Capex to operating cash flow
-0.07-0.18-0.09-0.37-0.07
Capex to revenue
-0.01-0.02-0.02-0.06-0.02
Capex to depreciation
-0.58-0.9-0.95-2.6-0.85
Stock based compensation to revenue
0.030.020.020.020.02
Graham number
2.211.6711.525.20.85
ROIC
0.060.040.2-0.030
Return on tangible assets
0.110.050.39-0.110
Graham Net
-8.67-8.48-6.03-6.43-6.02
Working capital
32.78M23.43M136.46M108.48M113.92M
Tangible asset value
-337.48M-328.94M-223.06M-244.82M-235.78M
Net current asset value
-391.74M-380.06M-261.48M-283.73M-276.04M
Invested capital
16.111.532.833.33.04
Average receivables
41.36M53.17M62.28M64.89M61.92M
Average payables
19.07M18.69M20.09M23.26M25.35M
Average inventory
00000
Days sales outstanding
38.0945.4245.5846.7240.94
Days payables outstanding
28.9124.8925.5929.2929.13
Days of inventory on hand
00000
Receivables turnover
2.361.981.971.932.2
Payables turnover
3.113.623.523.073.09
Inventory turnover
00000
ROE
0.760.250.74-0.210.01
Capex per share
-0.03-0.05-0.05-0.16-0.05

TVTY Frequently Asked Questions

What is Tivity Health, Inc. stock symbol ?

Tivity Health, Inc. is a US stock , located in Franklin of Tennessee and trading under the symbol TVTY

What is Tivity Health, Inc. stock quote today ?

Tivity Health, Inc. stock price is $- today.

Is Tivity Health, Inc. stock public?

Yes, Tivity Health, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Check Those